% Options for packages loaded elsewhere
\PassOptionsToPackage{unicode}{hyperref}
\PassOptionsToPackage{hyphens}{url}
\PassOptionsToPackage{dvipsnames,svgnames,x11names}{xcolor}
%
\documentclass[
  letterpaper,
  DIV=11,
  numbers=noendperiod]{scrartcl}

\usepackage{amsmath,amssymb}
\usepackage{iftex}
\ifPDFTeX
  \usepackage[T1]{fontenc}
  \usepackage[utf8]{inputenc}
  \usepackage{textcomp} % provide euro and other symbols
\else % if luatex or xetex
  \usepackage{unicode-math}
  \defaultfontfeatures{Scale=MatchLowercase}
  \defaultfontfeatures[\rmfamily]{Ligatures=TeX,Scale=1}
\fi
\usepackage{lmodern}
\ifPDFTeX\else  
    % xetex/luatex font selection
\fi
% Use upquote if available, for straight quotes in verbatim environments
\IfFileExists{upquote.sty}{\usepackage{upquote}}{}
\IfFileExists{microtype.sty}{% use microtype if available
  \usepackage[]{microtype}
  \UseMicrotypeSet[protrusion]{basicmath} % disable protrusion for tt fonts
}{}
\makeatletter
\@ifundefined{KOMAClassName}{% if non-KOMA class
  \IfFileExists{parskip.sty}{%
    \usepackage{parskip}
  }{% else
    \setlength{\parindent}{0pt}
    \setlength{\parskip}{6pt plus 2pt minus 1pt}}
}{% if KOMA class
  \KOMAoptions{parskip=half}}
\makeatother
\usepackage{xcolor}
\setlength{\emergencystretch}{3em} % prevent overfull lines
\setcounter{secnumdepth}{-\maxdimen} % remove section numbering
% Make \paragraph and \subparagraph free-standing
\ifx\paragraph\undefined\else
  \let\oldparagraph\paragraph
  \renewcommand{\paragraph}[1]{\oldparagraph{#1}\mbox{}}
\fi
\ifx\subparagraph\undefined\else
  \let\oldsubparagraph\subparagraph
  \renewcommand{\subparagraph}[1]{\oldsubparagraph{#1}\mbox{}}
\fi


\providecommand{\tightlist}{%
  \setlength{\itemsep}{0pt}\setlength{\parskip}{0pt}}\usepackage{longtable,booktabs,array}
\usepackage{calc} % for calculating minipage widths
% Correct order of tables after \paragraph or \subparagraph
\usepackage{etoolbox}
\makeatletter
\patchcmd\longtable{\par}{\if@noskipsec\mbox{}\fi\par}{}{}
\makeatother
% Allow footnotes in longtable head/foot
\IfFileExists{footnotehyper.sty}{\usepackage{footnotehyper}}{\usepackage{footnote}}
\makesavenoteenv{longtable}
\usepackage{graphicx}
\makeatletter
\def\maxwidth{\ifdim\Gin@nat@width>\linewidth\linewidth\else\Gin@nat@width\fi}
\def\maxheight{\ifdim\Gin@nat@height>\textheight\textheight\else\Gin@nat@height\fi}
\makeatother
% Scale images if necessary, so that they will not overflow the page
% margins by default, and it is still possible to overwrite the defaults
% using explicit options in \includegraphics[width, height, ...]{}
\setkeys{Gin}{width=\maxwidth,height=\maxheight,keepaspectratio}
% Set default figure placement to htbp
\makeatletter
\def\fps@figure{htbp}
\makeatother

\KOMAoption{captions}{tableheading}
\makeatletter
\@ifpackageloaded{caption}{}{\usepackage{caption}}
\AtBeginDocument{%
\ifdefined\contentsname
  \renewcommand*\contentsname{Table of contents}
\else
  \newcommand\contentsname{Table of contents}
\fi
\ifdefined\listfigurename
  \renewcommand*\listfigurename{List of Figures}
\else
  \newcommand\listfigurename{List of Figures}
\fi
\ifdefined\listtablename
  \renewcommand*\listtablename{List of Tables}
\else
  \newcommand\listtablename{List of Tables}
\fi
\ifdefined\figurename
  \renewcommand*\figurename{Figure}
\else
  \newcommand\figurename{Figure}
\fi
\ifdefined\tablename
  \renewcommand*\tablename{Table}
\else
  \newcommand\tablename{Table}
\fi
}
\@ifpackageloaded{float}{}{\usepackage{float}}
\floatstyle{ruled}
\@ifundefined{c@chapter}{\newfloat{codelisting}{h}{lop}}{\newfloat{codelisting}{h}{lop}[chapter]}
\floatname{codelisting}{Listing}
\newcommand*\listoflistings{\listof{codelisting}{List of Listings}}
\makeatother
\makeatletter
\makeatother
\makeatletter
\@ifpackageloaded{caption}{}{\usepackage{caption}}
\@ifpackageloaded{subcaption}{}{\usepackage{subcaption}}
\makeatother
\ifLuaTeX
  \usepackage{selnolig}  % disable illegal ligatures
\fi
\usepackage{bookmark}

\IfFileExists{xurl.sty}{\usepackage{xurl}}{} % add URL line breaks if available
\urlstyle{same} % disable monospaced font for URLs
\hypersetup{
  pdftitle={Development and Validation of a Risk Prediction Model of linezolid-induced thrombocytopenia in Vietnamese patients},
  colorlinks=true,
  linkcolor={blue},
  filecolor={Maroon},
  citecolor={Blue},
  urlcolor={Blue},
  pdfcreator={LaTeX via pandoc}}

\title{Development and Validation of a Risk Prediction Model of
linezolid-induced thrombocytopenia in Vietnamese patients}
\author{}
\date{Friday, March 8, 2024}

\begin{document}
\maketitle

\subsection{Objectives}\label{objectives}

\begin{enumerate}
\def\labelenumi{\arabic{enumi}.}
\tightlist
\item
  Investigating risk factors of linezolid-induced thrombocytopenia
  (LI-TP)
\item
  Developing and validating a logistics regression model to predict
  LI-TP in Vietnamese patients
\end{enumerate}

\subsection{Data cleaning}\label{data-cleaning}

\textsubscript{Source:
\href{https://AnTangQuoc.github.io/LZD-TP-pred-model/index.qmd.html}{Article
Notebook}}

\begin{verbatim}
Rows: 817
Columns: 58
$ patient_age          <dbl> 90, 80, 79, 71, 72, 61, 60, 64, 92, 75, 86, 93, 6~
$ patient_sex          <lgl> TRUE, TRUE, FALSE, FALSE, TRUE, FALSE, FALSE, TRU~
$ LZD_dose_per_weight  <dbl> 25.00000, 30.00000, 30.00000, 13.33333, 17.14286,~
$ baseline_CLCR        <dbl> 27.22860, 63.15805, 29.93031, 50.89929, 10.87932,~
$ dept_ER              <lgl> TRUE, FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, T~
$ dept_ICU             <lgl> FALSE, TRUE, TRUE, TRUE, TRUE, TRUE, TRUE, FALSE,~
$ baseline_HGB         <dbl> 96, 101, 86, 94, 86, 99, 98, 119, 60, 118, 99, 10~
$ baseline_WBC         <dbl> 6.75, 11.91, 14.05, 14.61, 7.92, 21.79, 13.27, 6.~
$ baseline_PLT         <dbl> 244, 180, 259, 179, 236, 113, 196, 154, 147, 101,~
$ LZD_duration         <dbl> 6, 8, 15, 3, 7, 8, 22, 4, 3, 16, 14, 7, 13, 20, 6~
$ invasive_ETI         <lgl> FALSE, FALSE, FALSE, TRUE, TRUE, FALSE, TRUE, FAL~
$ invasive_CVC         <lgl> FALSE, FALSE, TRUE, FALSE, TRUE, FALSE, TRUE, FAL~
$ invasive_IHD         <lgl> FALSE, FALSE, FALSE, FALSE, TRUE, FALSE, FALSE, F~
$ invasive_CRRT        <lgl> FALSE, FALSE, FALSE, TRUE, FALSE, FALSE, FALSE, F~
$ comorb_HTN           <lgl> TRUE, TRUE, TRUE, TRUE, TRUE, FALSE, FALSE, TRUE,~
$ comorb_DM            <lgl> TRUE, FALSE, FALSE, FALSE, TRUE, TRUE, FALSE, FAL~
$ comorb_HF            <lgl> FALSE, TRUE, TRUE, TRUE, TRUE, FALSE, FALSE, TRUE~
$ comorb_angina        <lgl> FALSE, TRUE, TRUE, FALSE, FALSE, FALSE, FALSE, FA~
$ comorb_cirr          <lgl> FALSE, FALSE, FALSE, FALSE, FALSE, TRUE, FALSE, F~
$ comorb_COPD          <lgl> FALSE, FALSE, FALSE, TRUE, FALSE, FALSE, FALSE, F~
$ comorb_CVA           <lgl> FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, ~
$ comorb_MI            <lgl> FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, ~
$ comorb_K             <lgl> FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, TRUE, F~
$ comorb_hematological <lgl> FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, ~
$ comorb_hema          <lgl> FALSE, FALSE, FALSE, TRUE, FALSE, FALSE, FALSE, F~
$ infect_sepsis        <lgl> FALSE, FALSE, FALSE, FALSE, FALSE, TRUE, TRUE, TR~
$ infect_CAP           <lgl> FALSE, FALSE, TRUE, FALSE, FALSE, FALSE, FALSE, F~
$ infect_HAP           <lgl> TRUE, FALSE, FALSE, TRUE, TRUE, FALSE, FALSE, TRU~
$ infect_SSTI          <lgl> FALSE, FALSE, FALSE, FALSE, TRUE, FALSE, FALSE, T~
$ infect_CNS           <lgl> FALSE, FALSE, FALSE, FALSE, FALSE, TRUE, FALSE, F~
$ infect_IAI           <lgl> FALSE, TRUE, FALSE, FALSE, FALSE, TRUE, TRUE, FAL~
$ infect_UTI           <lgl> FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, ~
$ infect_BJI           <lgl> FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, ~
$ infect_septicemia    <lgl> FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, ~
$ comed_aspirin        <lgl> FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, ~
$ comed_diclofenac     <lgl> FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, ~
$ comed_ibuprofen      <lgl> FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, ~
$ comed_paracetamol    <lgl> TRUE, TRUE, FALSE, FALSE, TRUE, TRUE, TRUE, TRUE,~
$ comed_penicillin     <lgl> FALSE, TRUE, TRUE, TRUE, TRUE, FALSE, TRUE, FALSE~
$ comed_cepha          <lgl> FALSE, FALSE, FALSE, FALSE, FALSE, TRUE, FALSE, F~
$ comed_carbapenem     <lgl> TRUE, TRUE, TRUE, FALSE, TRUE, TRUE, TRUE, TRUE, ~
$ comed_cotrimoxazol   <lgl> FALSE, TRUE, FALSE, FALSE, FALSE, FALSE, FALSE, F~
$ comed_vancomycin     <lgl> FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, ~
$ comed_levofloxacin   <lgl> FALSE, FALSE, FALSE, FALSE, TRUE, FALSE, FALSE, F~
$ comed_teicoplanin    <lgl> FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, ~
$ comed_ethambutol     <lgl> FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, ~
$ comed_pyrazinamid    <lgl> FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, ~
$ comed_rifampin       <lgl> FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, ~
$ comed_heparin        <lgl> FALSE, FALSE, FALSE, TRUE, TRUE, FALSE, FALSE, FA~
$ comed_clopidogrel    <lgl> FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, ~
$ comed_enoxaparin     <lgl> FALSE, FALSE, TRUE, TRUE, FALSE, TRUE, TRUE, FALS~
$ comed_dexamethason   <lgl> FALSE, FALSE, FALSE, FALSE, FALSE, TRUE, FALSE, F~
$ comed_amiodaron      <lgl> FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, ~
$ comed_furosemid      <lgl> FALSE, TRUE, TRUE, TRUE, TRUE, TRUE, TRUE, FALSE,~
$ comed_haloperidol    <lgl> FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, ~
$ comed_valproic       <lgl> FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, FALSE, ~
$ flag_ADR_TP_ID       <lgl> FALSE, FALSE, FALSE, FALSE, TRUE, TRUE, TRUE, FAL~
$ site                 <chr> "TN1", "TN1", "TN1", "TN1", "TN1", "TN1", "TN1", ~
\end{verbatim}

\textsubscript{Source:
\href{https://AnTangQuoc.github.io/LZD-TP-pred-model/index.qmd.html}{Article
Notebook}}

\subsection{Descriptive statistics}\label{descriptive-statistics}

\textsubscript{Source:
\href{https://AnTangQuoc.github.io/LZD-TP-pred-model/index.qmd.html}{Article
Notebook}}

\begin{longtable}[]{@{}
  >{\raggedright\arraybackslash}p{(\columnwidth - 12\tabcolsep) * \real{0.2083}}
  >{\centering\arraybackslash}p{(\columnwidth - 12\tabcolsep) * \real{0.1833}}
  >{\centering\arraybackslash}p{(\columnwidth - 12\tabcolsep) * \real{0.1667}}
  >{\centering\arraybackslash}p{(\columnwidth - 12\tabcolsep) * \real{0.1667}}
  >{\centering\arraybackslash}p{(\columnwidth - 12\tabcolsep) * \real{0.0667}}
  >{\centering\arraybackslash}p{(\columnwidth - 12\tabcolsep) * \real{0.1000}}
  >{\centering\arraybackslash}p{(\columnwidth - 12\tabcolsep) * \real{0.1083}}@{}}
\toprule\noalign{}
\begin{minipage}[b]{\linewidth}\raggedright
\textbf{Characteristic}
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
\textbf{Overall}, N = 817
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
\textbf{FALSE}, N = 553
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
\textbf{TRUE}, N = 264
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
\textbf{OR}
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
\textbf{95\% CI}
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
\textbf{p-value}
\end{minipage} \\
\midrule\noalign{}
\endhead
\bottomrule\noalign{}
\endlastfoot
\textbf{patient\_age} & 62 (50 - 73) & 61 (47 - 72) & 64 (54 - 74) &
1.02 & 1.01, 1.03 & \textbf{\textless0.001} \\
\textbf{patient\_sex} & 307 (38\%) & 207 (37\%) & 100 (38\%) & 1.02 &
0.75, 1.38 & \textgreater0.9 \\
\textbf{LZD\_dose\_per\_weight} & 21.8 (20.0 - 24.0) & 21.8 (20.0 -
24.0) & 21.8 (19.4 - 24.6) & 0.99 & 0.96, 1.03 & 0.8 \\
\textbf{baseline\_CLCR} & 48 (21 - 83) & 55 (26 - 88) & 32 (15 - 64) &
0.99 & 0.99, 0.99 & \textbf{\textless0.001} \\
\textbf{dept\_ER} & 140 (17\%) & 95 (17\%) & 45 (17\%) & 0.99 & 0.67,
1.45 & \textgreater0.9 \\
\textbf{dept\_ICU} & 391 (48\%) & 241 (44\%) & 150 (57\%) & 1.70 & 1.27,
2.29 & \textbf{\textless0.001} \\
\textbf{baseline\_HGB} & 102 (89 - 120) & 105 (91 - 121) & 98 (85 - 117)
& 0.99 & 0.98, 0.99 & \textbf{\textless0.001} \\
\textbf{baseline\_WBC} & 12 (8 - 17) & 12 (8 - 17) & 12 (8 - 18) & 1.01
& 0.99, 1.03 & 0.4 \\
\textbf{baseline\_PLT} & 206 (142 - 288) & 234 (167 - 309) & 154 (103 -
211) & 0.99 & 0.99, 0.99 & \textbf{\textless0.001} \\
\textbf{LZD\_duration} & 9.0 (6.0 - 14.0) & 9.0 (6.0 - 13.0) & 10.0 (6.0
- 14.0) & 1.03 & 1.01, 1.06 & \textbf{0.018} \\
\textbf{invasive\_ETI} & 387 (47\%) & 231 (42\%) & 156 (59\%) & 2.01 &
1.50, 2.72 & \textbf{\textless0.001} \\
\textbf{invasive\_CVC} & 424 (52\%) & 247 (45\%) & 177 (67\%) & 2.52 &
1.86, 3.43 & \textbf{\textless0.001} \\
\textbf{invasive\_IHD} & 111 (14\%) & 64 (12\%) & 47 (18\%) & 1.65 &
1.10, 2.49 & \textbf{0.016} \\
\textbf{invasive\_CRRT} & 148 (18\%) & 65 (12\%) & 83 (31\%) & 3.44 &
2.39, 4.98 & \textbf{\textless0.001} \\
\textbf{comorb\_HTN} & 333 (41\%) & 218 (39\%) & 115 (44\%) & 1.19 &
0.88, 1.60 & 0.3 \\
\textbf{comorb\_DM} & 222 (27\%) & 150 (27\%) & 72 (27\%) & 1.01 & 0.72,
1.40 & \textgreater0.9 \\
\textbf{comorb\_HF} & 226 (28\%) & 132 (24\%) & 94 (36\%) & 1.76 & 1.28,
2.42 & \textbf{\textless0.001} \\
\textbf{comorb\_angina} & 32 (3.9\%) & 19 (3.4\%) & 13 (4.9\%) & 1.46 &
0.69, 2.97 & 0.3 \\
\textbf{comorb\_cirr} & 48 (5.9\%) & 20 (3.6\%) & 28 (11\%) & 3.16 &
1.75, 5.80 & \textbf{\textless0.001} \\
\textbf{comorb\_COPD} & 39 (4.8\%) & 25 (4.5\%) & 14 (5.3\%) & 1.18 &
0.59, 2.28 & 0.6 \\
\textbf{comorb\_CVA} & 93 (11\%) & 64 (12\%) & 29 (11\%) & 0.94 & 0.58,
1.49 & 0.8 \\
\textbf{comorb\_MI} & 20 (2.4\%) & 15 (2.7\%) & 5 (1.9\%) & 0.69 & 0.22,
1.81 & 0.5 \\
\textbf{comorb\_K} & 67 (8.2\%) & 44 (8.0\%) & 23 (8.7\%) & 1.10 & 0.64,
1.85 & 0.7 \\
\textbf{comorb\_hematological} & 46 (5.6\%) & 27 (4.9\%) & 19 (7.2\%) &
1.51 & 0.81, 2.75 & 0.2 \\
\textbf{comorb\_hema} & 61 (7.5\%) & 37 (6.7\%) & 24 (9.1\%) & 1.39 &
0.81, 2.37 & 0.2 \\
\textbf{infect\_sepsis} & 134 (16\%) & 66 (12\%) & 68 (26\%) & 2.56 &
1.76, 3.74 & \textbf{\textless0.001} \\
\textbf{infect\_CAP} & 118 (14\%) & 70 (13\%) & 48 (18\%) & 1.53 & 1.02,
2.28 & \textbf{0.037} \\
\textbf{infect\_HAP} & 375 (46\%) & 255 (46\%) & 120 (45\%) & 0.97 &
0.73, 1.31 & 0.9 \\
\textbf{infect\_SSTI} & 133 (16\%) & 100 (18\%) & 33 (13\%) & 0.65 &
0.42, 0.98 & \textbf{0.044} \\
\textbf{infect\_CNS} & 68 (8.3\%) & 46 (8.3\%) & 22 (8.3\%) & 1.00 &
0.58, 1.68 & \textgreater0.9 \\
\textbf{infect\_IAI} & 50 (6.1\%) & 34 (6.1\%) & 16 (6.1\%) & 0.98 &
0.52, 1.79 & \textgreater0.9 \\
\textbf{infect\_UTI} & 53 (6.5\%) & 37 (6.7\%) & 16 (6.1\%) & 0.90 &
0.48, 1.62 & 0.7 \\
\textbf{infect\_BJI} & 11 (1.3\%) & 10 (1.8\%) & 1 (0.4\%) & 0.21 &
0.01, 1.09 & 0.13 \\
\textbf{infect\_septicemia} & 237 (29\%) & 148 (27\%) & 89 (34\%) & 1.39
& 1.01, 1.91 & \textbf{0.041} \\
\textbf{comed\_aspirin} & 47 (5.8\%) & 30 (5.4\%) & 17 (6.4\%) & 1.20 &
0.64, 2.19 & 0.6 \\
\textbf{comed\_diclofenac} & 27 (3.3\%) & 20 (3.6\%) & 7 (2.7\%) & 0.73
& 0.28, 1.66 & 0.5 \\
\textbf{comed\_ibuprofen} & 26 (3.2\%) & 15 (2.7\%) & 11 (4.2\%) & 1.56
& 0.69, 3.42 & 0.3 \\
\textbf{comed\_paracetamol} & 355 (43\%) & 244 (44\%) & 111 (42\%) &
0.92 & 0.68, 1.23 & 0.6 \\
\textbf{comed\_penicillin} & 123 (15\%) & 78 (14\%) & 45 (17\%) & 1.25 &
0.83, 1.86 & 0.3 \\
\textbf{comed\_cepha} & 207 (25\%) & 149 (27\%) & 58 (22\%) & 0.76 &
0.54, 1.08 & 0.13 \\
\textbf{comed\_carbapenem} & 584 (71\%) & 382 (69\%) & 202 (77\%) & 1.46
& 1.05, 2.05 & \textbf{0.028} \\
\textbf{comed\_cotrimoxazol} & 65 (8.0\%) & 37 (6.7\%) & 28 (11\%) &
1.65 & 0.98, 2.76 & 0.055 \\
\textbf{comed\_vancomycin} & 68 (8.3\%) & 42 (7.6\%) & 26 (9.8\%) & 1.33
& 0.79, 2.21 & 0.3 \\
\textbf{comed\_levofloxacin} & 250 (31\%) & 161 (29\%) & 89 (34\%) &
1.24 & 0.90, 1.69 & 0.2 \\
\textbf{comed\_teicoplanin} & 37 (4.5\%) & 23 (4.2\%) & 14 (5.3\%) &
1.29 & 0.64, 2.52 & 0.5 \\
\textbf{comed\_ethambutol} & 8 (1.0\%) & 5 (0.9\%) & 3 (1.1\%) & 1.26 &
0.26, 5.17 & 0.8 \\
\textbf{comed\_pyrazinamid} & 12 (1.5\%) & 6 (1.1\%) & 6 (2.3\%) & 2.12
& 0.66, 6.84 & 0.2 \\
\textbf{comed\_rifampin} & 17 (2.1\%) & 10 (1.8\%) & 7 (2.7\%) & 1.48 &
0.53, 3.89 & 0.4 \\
\textbf{comed\_heparin} & 207 (25\%) & 108 (20\%) & 99 (38\%) & 2.47 &
1.78, 3.43 & \textbf{\textless0.001} \\
\textbf{comed\_clopidogrel} & 40 (4.9\%) & 30 (5.4\%) & 10 (3.8\%) &
0.69 & 0.31, 1.38 & 0.3 \\
\textbf{comed\_enoxaparin} & 350 (43\%) & 233 (42\%) & 117 (44\%) & 1.09
& 0.81, 1.47 & 0.6 \\
\textbf{comed\_dexamethason} & 105 (13\%) & 71 (13\%) & 34 (13\%) & 1.00
& 0.64, 1.54 & \textgreater0.9 \\
\textbf{comed\_amiodaron} & 36 (4.4\%) & 17 (3.1\%) & 19 (7.2\%) & 2.45
& 1.25, 4.83 & \textbf{0.009} \\
\textbf{comed\_furosemid} & 436 (53\%) & 260 (47\%) & 176 (67\%) & 2.25
& 1.66, 3.07 & \textbf{\textless0.001} \\
\textbf{comed\_haloperidol} & 52 (6.4\%) & 35 (6.3\%) & 17 (6.4\%) &
1.02 & 0.55, 1.83 & \textgreater0.9 \\
\textbf{comed\_valproic} & 32 (3.9\%) & 23 (4.2\%) & 9 (3.4\%) & 0.81 &
0.35, 1.73 & 0.6 \\
\textbf{comed\_aceclofenac} & 0 (0\%) & 0 (0\%) & 0 (0\%) & & & \\
\textbf{comed\_naproxen} & 0 (0\%) & 0 (0\%) & 0 (0\%) & & & \\
\textbf{comed\_daptomycin} & 1 (0.1\%) & 0 (0\%) & 1 (0.4\%) & & & \\
\textbf{comed\_cetirizin} & 6 (0.7\%) & 5 (0.9\%) & 1 (0.4\%) & & & \\
\textbf{comed\_simvas} & 0 (0\%) & 0 (0\%) & 0 (0\%) & & & \\
\textbf{comed\_bisoprolol} & 6 (0.7\%) & 4 (0.7\%) & 2 (0.8\%) & & & \\
\textbf{comed\_diltiazem} & 0 (0\%) & 0 (0\%) & 0 (0\%) & & & \\
\textbf{comed\_eptifibatid} & 0 (0\%) & 0 (0\%) & 0 (0\%) & & & \\
\textbf{comed\_quinidin} & 0 (0\%) & 0 (0\%) & 0 (0\%) & & & \\
\textbf{comed\_carbamazepin} & 8 (1.0\%) & 8 (1.4\%) & 0 (0\%) & & & \\
\textbf{comed\_phenytoin} & 0 (0\%) & 0 (0\%) & 0 (0\%) & & & \\
\textbf{comed\_mirtazapin} & 0 (0\%) & 0 (0\%) & 0 (0\%) & & & \\
\textbf{comed\_quetiapin} & 4 (0.5\%) & 4 (0.7\%) & 0 (0\%) & & & \\
\textbf{comed\_ondansetron} & 6 (0.7\%) & 4 (0.7\%) & 2 (0.8\%) & & & \\
\textbf{comed\_palonosetron} & 0 (0\%) & 0 (0\%) & 0 (0\%) & & & \\
\textbf{comed\_oseltamivir} & 3 (0.4\%) & 1 (0.2\%) & 2 (0.8\%) & & & \\
\textbf{comed\_quinin} & 0 (0\%) & 0 (0\%) & 0 (0\%) & & & \\
\textbf{comed\_pembrolizumab} & 0 (0\%) & 0 (0\%) & 0 (0\%) & & & \\
\textbf{comed\_trastuzumab} & 0 (0\%) & 0 (0\%) & 0 (0\%) & & & \\
\textbf{comed\_atezolizumab} & 0 (0\%) & 0 (0\%) & 0 (0\%) & & & \\
\textbf{comed\_durvalumab} & 0 (0\%) & 0 (0\%) & 0 (0\%) & & & \\
\textbf{comed\_IVIG} & 0 (0\%) & 0 (0\%) & 0 (0\%) & & & \\
\textbf{comed\_tacrolimus} & 1 (0.1\%) & 0 (0\%) & 1 (0.4\%) & & & \\
\textbf{comed\_fluorouracil} & 0 (0\%) & 0 (0\%) & 0 (0\%) & & & \\
\textbf{comed\_irinotecan} & 0 (0\%) & 0 (0\%) & 0 (0\%) & & & \\
\textbf{comed\_leucovorin} & 0 (0\%) & 0 (0\%) & 0 (0\%) & & & \\
\textbf{comed\_oxaliplatin} & 0 (0\%) & 0 (0\%) & 0 (0\%) & & & \\
\end{longtable}

\textsubscript{Source:
\href{https://AnTangQuoc.github.io/LZD-TP-pred-model/index.qmd.html}{Article
Notebook}}

\textsubscript{Source:
\href{https://AnTangQuoc.github.io/LZD-TP-pred-model/index.qmd.html}{Article
Notebook}}

\begin{longtable}[]{@{}
  >{\raggedright\arraybackslash}p{(\columnwidth - 16\tabcolsep) * \real{0.1389}}
  >{\centering\arraybackslash}p{(\columnwidth - 16\tabcolsep) * \real{0.1222}}
  >{\centering\arraybackslash}p{(\columnwidth - 16\tabcolsep) * \real{0.1111}}
  >{\centering\arraybackslash}p{(\columnwidth - 16\tabcolsep) * \real{0.1111}}
  >{\centering\arraybackslash}p{(\columnwidth - 16\tabcolsep) * \real{0.1111}}
  >{\centering\arraybackslash}p{(\columnwidth - 16\tabcolsep) * \real{0.1111}}
  >{\centering\arraybackslash}p{(\columnwidth - 16\tabcolsep) * \real{0.1111}}
  >{\centering\arraybackslash}p{(\columnwidth - 16\tabcolsep) * \real{0.1111}}
  >{\centering\arraybackslash}p{(\columnwidth - 16\tabcolsep) * \real{0.0722}}@{}}
\toprule\noalign{}
\begin{minipage}[b]{\linewidth}\raggedright
\textbf{Characteristic}
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
\textbf{Overall}, N = 817
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
\textbf{BM1}, N = 125
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
\textbf{BM2}, N = 77
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
\textbf{ND1}, N = 180
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
\textbf{ND2}, N = 116
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
\textbf{TN1}, N = 100
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
\textbf{TN2}, N = 219
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
\textbf{p-value}
\end{minipage} \\
\midrule\noalign{}
\endhead
\bottomrule\noalign{}
\endlastfoot
\textbf{patient\_age} & 62 (50 - 73) & 58 (43 - 69) & 60 (45 - 72) & 60
(45 - 68) & 59 (46 - 68) & 69 (60 - 78) & 66 (58 - 78) &
\textbf{\textless0.001} \\
\textbf{patient\_sex} & 307 (38\%) & 54 (43\%) & 27 (35\%) & 74 (41\%) &
28 (24\%) & 48 (48\%) & 76 (35\%) & \textbf{0.004} \\
\textbf{LZD\_dose\_per\_weight} & 21.8 (20.0 - 24.0) & 22.6 (20.0 -
25.5) & 21.4 (19.0 - 24.0) & 21.4 (19.4 - 24.0) & 21.8 (20.0 - 24.0) &
24.0 (20.0 - 24.6) & 21.8 (19.7 - 24.0) & \textbf{0.027} \\
\textbf{baseline\_CLCR} & 48 (21 - 83) & 50 (24 - 80) & 40 (17 - 86) &
70 (41 - 104) & 60 (27 - 95) & 29 (14 - 54) & 35 (17 - 67) &
\textbf{\textless0.001} \\
\textbf{dept\_ER} & 140 (17\%) & 7 (5.6\%) & 9 (12\%) & 67 (37\%) & 15
(13\%) & 16 (16\%) & 26 (12\%) & \textbf{\textless0.001} \\
\textbf{dept\_ICU} & 391 (48\%) & 10 (8.0\%) & 23 (30\%) & 74 (41\%) &
42 (36\%) & 77 (77\%) & 165 (75\%) & \textbf{\textless0.001} \\
\textbf{baseline\_HGB} & 102 (89 - 120) & 105 (91 - 124) & 99 (83 - 118)
& 105 (89 - 122) & 100 (88 - 118) & 99 (89 - 116) & 104 (91 - 120) &
0.2 \\
\textbf{baseline\_WBC} & 12 (8 - 17) & 11 (7 - 16) & 11 (7 - 17) & 12 (8
- 18) & 11 (7 - 15) & 12 (8 - 18) & 13 (9 - 18) & \textbf{0.024} \\
\textbf{baseline\_PLT} & 206 (142 - 288) & 195 (139 - 247) & 234 (160 -
318) & 207 (129 - 292) & 225 (127 - 310) & 172 (122 - 245) & 225 (161 -
299) & \textbf{\textless0.001} \\
\textbf{LZD\_duration} & 9.0 (6.0 - 14.0) & 8.0 (6.0 - 13.0) & 10.0 (6.0
- 14.0) & 10.0 (6.0 - 14.0) & 9.0 (6.0 - 12.0) & 11.0 (6.0 - 15.0) & 9.0
(6.0 - 12.0) & 0.3 \\
\textbf{invasive\_ETI} & 387 (47\%) & 63 (50\%) & 30 (39\%) & 112 (62\%)
& 49 (42\%) & 48 (48\%) & 85 (39\%) & \textbf{\textless0.001} \\
\textbf{invasive\_CVC} & 424 (52\%) & 75 (60\%) & 30 (39\%) & 100 (56\%)
& 48 (41\%) & 50 (50\%) & 121 (55\%) & \textbf{0.008} \\
\textbf{invasive\_IHD} & 111 (14\%) & 17 (14\%) & 16 (21\%) & 9 (5.0\%)
& 0 (0\%) & 27 (27\%) & 42 (19\%) & \textbf{\textless0.001} \\
\textbf{invasive\_CRRT} & 148 (18\%) & 17 (14\%) & 9 (12\%) & 53 (29\%)
& 5 (4.3\%) & 20 (20\%) & 44 (20\%) & \textbf{\textless0.001} \\
\textbf{comorb\_HTN} & 333 (41\%) & 42 (34\%) & 31 (40\%) & 49 (27\%) &
28 (24\%) & 59 (59\%) & 124 (57\%) & \textbf{\textless0.001} \\
\textbf{comorb\_DM} & 222 (27\%) & 28 (22\%) & 24 (31\%) & 28 (16\%) &
27 (23\%) & 31 (31\%) & 84 (38\%) & \textbf{\textless0.001} \\
\textbf{comorb\_HF} & 226 (28\%) & 55 (44\%) & 11 (14\%) & 15 (8.3\%) &
7 (6.0\%) & 70 (70\%) & 68 (31\%) & \textbf{\textless0.001} \\
\textbf{comorb\_angina} & 32 (3.9\%) & 0 (0\%) & 0 (0\%) & 1 (0.6\%) & 0
(0\%) & 13 (13\%) & 18 (8.2\%) & \textbf{\textless0.001} \\
\textbf{comorb\_cirr} & 48 (5.9\%) & 6 (4.8\%) & 1 (1.3\%) & 10 (5.6\%)
& 5 (4.3\%) & 12 (12\%) & 14 (6.4\%) & 0.080 \\
\textbf{comorb\_COPD} & 39 (4.8\%) & 3 (2.4\%) & 0 (0\%) & 2 (1.1\%) & 2
(1.7\%) & 9 (9.0\%) & 23 (11\%) & \textbf{\textless0.001} \\
\textbf{comorb\_CVA} & 93 (11\%) & 19 (15\%) & 11 (14\%) & 6 (3.3\%) & 4
(3.4\%) & 16 (16\%) & 37 (17\%) & \textbf{\textless0.001} \\
\textbf{comorb\_MI} & 20 (2.4\%) & 10 (8.0\%) & 3 (3.9\%) & 2 (1.1\%) &
0 (0\%) & 1 (1.0\%) & 4 (1.8\%) & \textbf{0.002} \\
\textbf{comorb\_K} & 67 (8.2\%) & 5 (4.0\%) & 5 (6.5\%) & 8 (4.4\%) & 6
(5.2\%) & 11 (11\%) & 32 (15\%) & \textbf{\textless0.001} \\
\textbf{comorb\_hematological} & 46 (5.6\%) & 9 (7.2\%) & 12 (16\%) & 10
(5.6\%) & 5 (4.3\%) & 8 (8.0\%) & 2 (0.9\%) & \textbf{\textless0.001} \\
\textbf{comorb\_hema} & 61 (7.5\%) & 13 (10\%) & 17 (22\%) & 14 (7.8\%)
& 2 (1.7\%) & 13 (13\%) & 2 (0.9\%) & \textbf{\textless0.001} \\
\textbf{infect\_sepsis} & 134 (16\%) & 10 (8.0\%) & 14 (18\%) & 16
(8.9\%) & 15 (13\%) & 44 (44\%) & 35 (16\%) & \textbf{\textless0.001} \\
\textbf{infect\_CAP} & 118 (14\%) & 7 (5.6\%) & 6 (7.8\%) & 11 (6.1\%) &
1 (0.9\%) & 26 (26\%) & 67 (31\%) & \textbf{\textless0.001} \\
\textbf{infect\_HAP} & 375 (46\%) & 38 (30\%) & 33 (43\%) & 93 (52\%) &
59 (51\%) & 52 (52\%) & 100 (46\%) & \textbf{0.004} \\
\textbf{infect\_SSTI} & 133 (16\%) & 33 (26\%) & 34 (44\%) & 1 (0.6\%) &
4 (3.4\%) & 23 (23\%) & 38 (17\%) & \textbf{\textless0.001} \\
\textbf{infect\_CNS} & 68 (8.3\%) & 0 (0\%) & 5 (6.5\%) & 24 (13\%) & 20
(17\%) & 4 (4.0\%) & 15 (6.8\%) & \textbf{\textless0.001} \\
\textbf{infect\_IAI} & 50 (6.1\%) & 8 (6.4\%) & 8 (10\%) & 1 (0.6\%) & 2
(1.7\%) & 12 (12\%) & 19 (8.7\%) & \textbf{\textless0.001} \\
\textbf{infect\_UTI} & 53 (6.5\%) & 6 (4.8\%) & 8 (10\%) & 10 (5.6\%) &
5 (4.3\%) & 4 (4.0\%) & 20 (9.1\%) & 0.3 \\
\textbf{infect\_BJI} & 11 (1.3\%) & 3 (2.4\%) & 0 (0\%) & 0 (0\%) & 2
(1.7\%) & 1 (1.0\%) & 5 (2.3\%) & 0.2 \\
\textbf{infect\_septicemia} & 237 (29\%) & 35 (28\%) & 24 (31\%) & 57
(32\%) & 60 (52\%) & 7 (7.0\%) & 54 (25\%) & \textbf{\textless0.001} \\
\textbf{comed\_aspirin} & 47 (5.8\%) & 8 (6.4\%) & 9 (12\%) & 3 (1.7\%)
& 0 (0\%) & 5 (5.0\%) & 22 (10\%) & \textbf{\textless0.001} \\
\textbf{comed\_diclofenac} & 27 (3.3\%) & 24 (19\%) & 0 (0\%) & 0 (0\%)
& 1 (0.9\%) & 0 (0\%) & 2 (0.9\%) & \textbf{\textless0.001} \\
\textbf{comed\_ibuprofen} & 26 (3.2\%) & 0 (0\%) & 0 (0\%) & 0 (0\%) & 2
(1.7\%) & 0 (0\%) & 24 (11\%) & \textbf{\textless0.001} \\
\textbf{comed\_paracetamol} & 355 (43\%) & 66 (53\%) & 0 (0\%) & 90
(50\%) & 69 (59\%) & 47 (47\%) & 83 (38\%) & \textbf{\textless0.001} \\
\textbf{comed\_penicillin} & 123 (15\%) & 0 (0\%) & 5 (6.5\%) & 34
(19\%) & 19 (16\%) & 17 (17\%) & 48 (22\%) & \textbf{\textless0.001} \\
\textbf{comed\_cepha} & 207 (25\%) & 12 (9.6\%) & 10 (13\%) & 35 (19\%)
& 33 (28\%) & 11 (11\%) & 106 (48\%) & \textbf{\textless0.001} \\
\textbf{comed\_carbapenem} & 584 (71\%) & 52 (42\%) & 46 (60\%) & 154
(86\%) & 78 (67\%) & 80 (80\%) & 174 (79\%) & \textbf{\textless0.001} \\
\textbf{comed\_cotrimoxazol} & 65 (8.0\%) & 0 (0\%) & 5 (6.5\%) & 18
(10\%) & 14 (12\%) & 9 (9.0\%) & 19 (8.7\%) & \textbf{0.010} \\
\textbf{comed\_vancomycin} & 68 (8.3\%) & 8 (6.4\%) & 3 (3.9\%) & 11
(6.1\%) & 22 (19\%) & 3 (3.0\%) & 21 (9.6\%) &
\textbf{\textless0.001} \\
\textbf{comed\_levofloxacin} & 250 (31\%) & 27 (22\%) & 6 (7.8\%) & 24
(13\%) & 20 (17\%) & 34 (34\%) & 139 (63\%) & \textbf{\textless0.001} \\
\textbf{comed\_teicoplanin} & 37 (4.5\%) & 0 (0\%) & 0 (0\%) & 7 (3.9\%)
& 2 (1.7\%) & 0 (0\%) & 28 (13\%) & \textbf{\textless0.001} \\
\textbf{comed\_ethambutol} & 8 (1.0\%) & 0 (0\%) & 0 (0\%) & 2 (1.1\%) &
6 (5.2\%) & 0 (0\%) & 0 (0\%) & \textbf{\textless0.001} \\
\textbf{comed\_pyrazinamid} & 12 (1.5\%) & 0 (0\%) & 0 (0\%) & 5 (2.8\%)
& 7 (6.0\%) & 0 (0\%) & 0 (0\%) & \textbf{\textless0.001} \\
\textbf{comed\_rifampin} & 17 (2.1\%) & 0 (0\%) & 0 (0\%) & 7 (3.9\%) &
9 (7.8\%) & 1 (1.0\%) & 0 (0\%) & \textbf{\textless0.001} \\
\textbf{comed\_heparin} & 207 (25\%) & 12 (9.6\%) & 2 (2.6\%) & 74
(41\%) & 24 (21\%) & 33 (33\%) & 62 (28\%) & \textbf{\textless0.001} \\
\textbf{comed\_clopidogrel} & 40 (4.9\%) & 7 (5.6\%) & 4 (5.2\%) & 1
(0.6\%) & 0 (0\%) & 8 (8.0\%) & 20 (9.1\%) & \textbf{\textless0.001} \\
\textbf{comed\_enoxaparin} & 350 (43\%) & 33 (26\%) & 13 (17\%) & 117
(65\%) & 44 (38\%) & 40 (40\%) & 103 (47\%) & \textbf{\textless0.001} \\
\textbf{comed\_dexamethason} & 105 (13\%) & 0 (0\%) & 0 (0\%) & 74
(41\%) & 20 (17\%) & 2 (2.0\%) & 9 (4.1\%) & \textbf{\textless0.001} \\
\textbf{comed\_amiodaron} & 36 (4.4\%) & 8 (6.4\%) & 0 (0\%) & 14
(7.8\%) & 5 (4.3\%) & 4 (4.0\%) & 5 (2.3\%) & \textbf{0.026} \\
\textbf{comed\_furosemid} & 436 (53\%) & 72 (58\%) & 15 (19\%) & 81
(45\%) & 49 (42\%) & 71 (71\%) & 148 (68\%) & \textbf{\textless0.001} \\
\textbf{comed\_haloperidol} & 52 (6.4\%) & 3 (2.4\%) & 4 (5.2\%) & 20
(11\%) & 4 (3.4\%) & 5 (5.0\%) & 16 (7.3\%) & \textbf{0.034} \\
\textbf{comed\_valproic} & 32 (3.9\%) & 0 (0\%) & 1 (1.3\%) & 10 (5.6\%)
& 5 (4.3\%) & 3 (3.0\%) & 13 (5.9\%) & \textbf{0.024} \\
\textbf{comed\_aceclofenac} & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0
(0\%) & 0 (0\%) & 0 (0\%) & \\
\textbf{comed\_naproxen} & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0
(0\%) & 0 (0\%) & 0 (0\%) & \\
\textbf{comed\_daptomycin} & 1 (0.1\%) & 0 (0\%) & 0 (0\%) & 0 (0\%) & 1
(0.9\%) & 0 (0\%) & 0 (0\%) & 0.4 \\
\textbf{comed\_cetirizin} & 6 (0.7\%) & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0
(0\%) & 0 (0\%) & 6 (2.7\%) & \textbf{0.016} \\
\textbf{comed\_simvas} & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0 (0\%)
& 0 (0\%) & 0 (0\%) & \\
\textbf{comed\_bisoprolol} & 6 (0.7\%) & 4 (3.2\%) & 0 (0\%) & 1 (0.6\%)
& 1 (0.9\%) & 0 (0\%) & 0 (0\%) & \textbf{0.031} \\
\textbf{comed\_diltiazem} & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0
(0\%) & 0 (0\%) & 0 (0\%) & \\
\textbf{comed\_eptifibatid} & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0
(0\%) & 0 (0\%) & 0 (0\%) & \\
\textbf{comed\_quinidin} & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0
(0\%) & 0 (0\%) & 0 (0\%) & \\
\textbf{comed\_carbamazepin} & 8 (1.0\%) & 0 (0\%) & 0 (0\%) & 7 (3.9\%)
& 0 (0\%) & 0 (0\%) & 1 (0.5\%) & \textbf{0.005} \\
\textbf{comed\_phenytoin} & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0
(0\%) & 0 (0\%) & 0 (0\%) & \\
\textbf{comed\_mirtazapin} & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0
(0\%) & 0 (0\%) & 0 (0\%) & \\
\textbf{comed\_quetiapin} & 4 (0.5\%) & 1 (0.8\%) & 1 (1.3\%) & 0 (0\%)
& 0 (0\%) & 0 (0\%) & 2 (0.9\%) & 0.5 \\
\textbf{comed\_ondansetron} & 6 (0.7\%) & 2 (1.6\%) & 1 (1.3\%) & 0
(0\%) & 3 (2.6\%) & 0 (0\%) & 0 (0\%) & \textbf{0.020} \\
\textbf{comed\_palonosetron} & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0
(0\%) & 0 (0\%) & 0 (0\%) & \\
\textbf{comed\_oseltamivir} & 3 (0.4\%) & 1 (0.8\%) & 1 (1.3\%) & 1
(0.6\%) & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0.4 \\
\textbf{comed\_quinin} & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0 (0\%)
& 0 (0\%) & 0 (0\%) & \\
\textbf{comed\_pembrolizumab} & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0 (0\%) &
0 (0\%) & 0 (0\%) & 0 (0\%) & \\
\textbf{comed\_trastuzumab} & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0
(0\%) & 0 (0\%) & 0 (0\%) & \\
\textbf{comed\_atezolizumab} & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0
(0\%) & 0 (0\%) & 0 (0\%) & \\
\textbf{comed\_durvalumab} & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0
(0\%) & 0 (0\%) & 0 (0\%) & \\
\textbf{comed\_IVIG} & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0 (0\%) &
0 (0\%) & 0 (0\%) & \\
\textbf{comed\_tacrolimus} & 1 (0.1\%) & 1 (0.8\%) & 0 (0\%) & 0 (0\%) &
0 (0\%) & 0 (0\%) & 0 (0\%) & 0.5 \\
\textbf{comed\_fluorouracil} & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0
(0\%) & 0 (0\%) & 0 (0\%) & \\
\textbf{comed\_irinotecan} & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0
(0\%) & 0 (0\%) & 0 (0\%) & \\
\textbf{comed\_leucovorin} & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0
(0\%) & 0 (0\%) & 0 (0\%) & \\
\textbf{comed\_oxaliplatin} & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0 (0\%) & 0
(0\%) & 0 (0\%) & 0 (0\%) & \\
\textbf{flag\_ADR\_TP\_ID} & 264 (32\%) & 34 (27\%) & 22 (29\%) & 59
(33\%) & 35 (30\%) & 38 (38\%) & 76 (35\%) & 0.5 \\
\textbf{ADR\_CTCAE\_max} & & & & & & & & \textbf{\textless0.001} \\
1 & 85 (32\%) & 11 (32\%) & 9 (41\%) & 17 (29\%) & 7 (20\%) & 7 (18\%) &
34 (45\%) & \\
2 & 78 (30\%) & 10 (29\%) & 6 (27\%) & 12 (20\%) & 6 (17\%) & 17 (45\%)
& 27 (36\%) & \\
3 & 49 (19\%) & 4 (12\%) & 3 (14\%) & 17 (29\%) & 7 (20\%) & 6 (16\%) &
12 (16\%) & \\
4 & 52 (20\%) & 9 (26\%) & 4 (18\%) & 13 (22\%) & 15 (43\%) & 8 (21\%) &
3 (3.9\%) & \\
\textbf{ADR\_onset\_first} & 4.0 (2.0 - 10.0) & 2.0 (1.0 - 9.8) & 3.5
(2.0 - 7.8) & 4.0 (2.0 - 9.0) & 6.0 (2.5 - 11.0) & 4.0 (2.0 - 9.0) & 6.0
(2.0 - 11.0) & 0.15 \\
\textbf{ADR\_PLT\_ratio} & 0.36 (0.22 - 0.52) & 0.55 (0.26 - 0.64) &
0.39 (0.21 - 0.58) & 0.37 (0.26 - 0.50) & 0.30 (0.16 - 0.45) & 0.36
(0.20 - 0.48) & 0.35 (0.25 - 0.50) & 0.077 \\
\end{longtable}

\textsubscript{Source:
\href{https://AnTangQuoc.github.io/LZD-TP-pred-model/index.qmd.html}{Article
Notebook}}

\subsection{Model Performance}\label{model-performance}

\begin{longtable}[]{@{}lrrr@{}}
\toprule\noalign{}
performance\_type & C\_index & calibration\_intercept &
calibration\_slope \\
\midrule\noalign{}
\endhead
\bottomrule\noalign{}
\endlastfoot
Apparent & 0.7805907 & 0.0000000 & 1.0000000 \\
Bootstrap & 0.7460291 & -0.0133039 & 0.8155761 \\
K-fold & 0.7508108 & -0.0206981 & 0.9113817 \\
\end{longtable}

\textsubscript{Source:
\href{https://AnTangQuoc.github.io/LZD-TP-pred-model/index.qmd.html}{Article
Notebook}}



\end{document}
